FindTrial
Sign In

ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study

ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06028451
Enrollment
550
Registered
2023-09-08
Start date
2023-09-25
Completion date
2024-12-15
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Aspergillosis

Keywords

invasive aspergillus infection

Brief summary

To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.

Detailed description

To assessed the current situation and outcome of critically ill patients with invasive aspergillus infection.

Interventions

OTHERRecord the information data

Record the information data

Sponsors

Southeast University, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age\>18 year-old * Diagosed as invasive aspergillus infection

Exclusion criteria

* Pregnant

Design outcomes

Primary

MeasureTime frame
mortality28 day

Countries

China

Contacts

Primary ContactJingyuan Xu, M.D.
13851417209@163.com8613851417209
Backup ContactJingyuan Xu, M.D.
13851417209@163.com13851417209

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026